Literature DB >> 9300067

Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls.

J F Kurtzke1, K Hyllested, J D Arbuckle, H Brønnum-Hansen, M T Wallin, A Heltberg, H Jacobsen, A Olsen, L S Eriksen.   

Abstract

Detailed questionnaires were completed in 1978-79 by 23 of the 28 then known resident Faroese multiple sclerosis (MS) patients and 127 controls. These controls were divided into 69 Group A (patient sibs and other relatives), 37 Group B (matched neighbor controls, their spouses and sibs, plus patient's spouse), and 21 Group C (distant matched controls, spouses, relatives living where MS patients never resided and British troops were not encamped during the war). No differences between cases and controls were found for education, occupation, types of residence, bathing, sanitary or drinking facilities, and nature of house construction or heating. Detailed dietary histories, available for half the subjects, revealed no differences, cases versus controls, for four age periods between age 0 and 30 years, and for 16 specified foodstuffs. Animal exposures showed overall no consistent differences by location or type of animal. There was a tendency to greater exposure to British troops during the war for cases versus Groups A and B but this did not attain statistical significance. Vaccinations for smallpox, tetanus and diphtheria were less common in the MS; no difference was found for other vaccinations. Except for a relative deficit in the cases for rubella and (insignificantly) for measles, mumps and chicken pox, reported illnesses were equally common among all groups. Operations, hospitalizations and injuries did not differentiate the groups, nor did age at menarche for women. Neurologic symptoms were significantly more common in the cases than in the controls.

Entities:  

Mesh:

Year:  1997        PMID: 9300067      PMCID: PMC7188329     

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  36 in total

1.  Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition.

Authors:  R L SWANK; O LERSTAD; A STRØM; J BACKER
Journal:  N Engl J Med       Date:  1952-05-08       Impact factor: 91.245

2.  Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, Cluster Focus. I. The water.

Authors:  D G Irvine; H B Schiefer; W J Hader
Journal:  Sci Total Environ       Date:  1989-08       Impact factor: 7.963

3.  Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics.

Authors:  J F Kurtzke; K Hyllested
Journal:  Acta Neurol Scand       Date:  1987-11       Impact factor: 3.209

4.  Mortality and migration in multiple sclerosis.

Authors:  J F Kurtzke; L T Kurland; I D Goldberg
Journal:  Neurology       Date:  1971-12       Impact factor: 9.910

5.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

6.  Further evidence of a possible association between house dogs and multiple sclerosis.

Authors:  S D Cook; B H Natelson; B E Levin; P S Chavis; P C Dowling
Journal:  Ann Neurol       Date:  1978-02       Impact factor: 10.422

7.  How multiple sclerosis is related to animal illness, stress and diabetes.

Authors:  S A Warren; K G Warren; S Greenhill; M Paterson
Journal:  Can Med Assoc J       Date:  1982-02-15       Impact factor: 8.262

8.  Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission.

Authors:  J F Kurtzke; K Hyllested; A Heltberg; A Olsen
Journal:  Acta Neurol Scand       Date:  1993-09       Impact factor: 3.209

9.  Multiple sclerosis in the Faroe Islands. VI. Studies of HLA markers.

Authors:  C Jersild; J F Kurtzke; K Riisom; A Heltberg; J Arbuckle; K Hyllested
Journal:  Tissue Antigens       Date:  1993-08

10.  Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies.

Authors:  K Lauer
Journal:  Acta Neurol Scand Suppl       Date:  1995
View more
  13 in total

Review 1.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

Review 2.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 3.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

5.  Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study.

Authors:  Adil Harroud; John A Morris; Vincenzo Forgetta; Ruth Mitchell; George Davey Smith; Stephen J Sawcer; J Brent Richards
Journal:  Neurology       Date:  2019-03-20       Impact factor: 9.910

6.  Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?

Authors:  A Diouf; H Trottier; T J Youbong; N F Ngom-Guéye; O Ndiaye; A Seck; D Sarr; S Diop; M Seydi; S Mboup; V K Nguyen; A Jaye
Journal:  Epidemiol Infect       Date:  2017-12-13       Impact factor: 2.451

Review 7.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

8.  Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau.

Authors:  Mette Lundsby Jensen; Sangeeta Dave; Maarten Schim van der Loeff; Carlos da Costa; Tim Vincent; Aleksandra Leligdowicz; Christine Stabell Benn; Adam Roth; Henrik Ravn; Ida Maria Lisse; Hilton Whittle; Peter Aaby
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

9.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

Review 10.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.